Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Sep-05-21 |
| | 10-Q | 10-K | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 8-K |
| Revenues: |
| Royalties | | | | | | | 30.8 | |
| Product Sales | | | | | | | 21.8 | |
| License Fees | | | | | | | 16.3 | |
| Other | | | | | | | 9.4 | |
| Medical Device revenues | 74.5 | 72.4 | | 70.3 | 69.5 | 79.0 | 78.3 | |
| Revenue growth [+] | -5.7% | -7.5% | | -9.9% | -15.0% | 12.5% | 9.6% | |
| Royalties | | | | | | | 7.6% | |
| Product Sales | | | | | | | 0.8% | |
| License Fees | | | | | | | 35.4% | |
| EBITDA | -18.2 | -14.6 | | -8.9 | -4.5 | 9.3 | 11.9 | |
| EBITDA margin | -24.5% | -20.1% | | -12.7% | -6.5% | 11.7% | 15.2% | |
| Depreciation and amortization | 8.1 | 8.4 | | 8.6 | 8.2 | 7.8 | 7.2 | |
| EBIT | -26.4 | -22.9 | | -17.5 | -12.7 | 1.5 | 4.7 | |
| EBIT margin | -35.4% | -31.7% | | -24.9% | -18.3% | 1.9% | 6.0% | |
| |
| Revenue Mix | 73.1% | 72.4% | | 71.8% | 71.7% | 74.6% | 74.4% | |
|